Cegui Hu

537 total citations
21 papers, 339 citations indexed

About

Cegui Hu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Cegui Hu has authored 21 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Cegui Hu's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Epigenetics and DNA Methylation (4 papers). Cegui Hu is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Epigenetics and DNA Methylation (4 papers). Cegui Hu collaborates with scholars based in China, Italy and United States. Cegui Hu's co-authors include Jinfeng Zhu, Wenjun Zhang, Hongliang Luo, Zhen Zong, Sumiya Dalangood, Hanjun Li, Jun Gui, Wen Qiao, Chen Luo and Lin Kang and has published in prestigious journals such as Cell Metabolism, Brain Research and Frontiers in Immunology.

In The Last Decade

Cegui Hu

20 papers receiving 333 citations

Peers

Cegui Hu
Xingyun Liao China
Lian Zuo China
Junya Peng China
Yong-Kil Hong South Korea
Jian Wen China
Ariungerel Gerelchuluun Japan
Linda Spiegelberg Netherlands
Ning Mu China
Yumiko Yamamura Japan
Xingyun Liao China
Cegui Hu
Citations per year, relative to Cegui Hu Cegui Hu (= 1×) peers Xingyun Liao

Countries citing papers authored by Cegui Hu

Since Specialization
Citations

This map shows the geographic impact of Cegui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cegui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cegui Hu more than expected).

Fields of papers citing papers by Cegui Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cegui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cegui Hu. The network helps show where Cegui Hu may publish in the future.

Co-authorship network of co-authors of Cegui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Cegui Hu. A scholar is included among the top collaborators of Cegui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cegui Hu. Cegui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hanjun, Wei Qiao, Cegui Hu, et al.. (2025). In Situ Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes. Cancer Immunology Research. 13(6). 939–956. 3 indexed citations
2.
Dalangood, Sumiya, Cegui Hu, Chenwei Yuan, et al.. (2025). Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis. Cell Reports. 44(11). 116526–116526.
3.
Qiao, Wen, Jingqi Chen, Cegui Hu, et al.. (2024). A Single‐Atom Manganese Nanozyme Mn‐N/C Promotes Anti‐Tumor Immune Response via Eliciting Type I Interferon Signaling. Advanced Science. 11(14). e2305979–e2305979. 48 indexed citations
4.
Hu, Cegui, Wen Qiao, Xiang Li, et al.. (2024). Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells. Cell Metabolism. 36(3). 630–647.e8. 47 indexed citations
5.
Qiao, Wen, Cegui Hu, Jiayi Ma, et al.. (2023). Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity. Cancer Letters. 573. 216370–216370. 6 indexed citations
6.
Liu, Jiang, et al.. (2023). Analysis and application of RNA binding protein gene pairs to predict the prognosis of gastric cancer. Heliyon. 9(7). e18242–e18242. 4 indexed citations
7.
8.
Zong, Zhen, et al.. (2022). Application of Machine Learning Algorithms to Predict Lymph Node Metastasis in Early Gastric Cancer. Frontiers in Medicine. 8. 759013–759013. 21 indexed citations
9.
Hu, Cegui, et al.. (2022). Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients. World Journal of Gastrointestinal Surgery. 14(6). 580–593. 7 indexed citations
10.
Luo, Chen, Lin Kang, Cegui Hu, et al.. (2021). LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Molecular Therapy — Nucleic Acids. 26. 523–535. 29 indexed citations
11.
Zong, Zhen, et al.. (2021). Nine-long non-coding ribonucleic acid signature can improve the survival prediction of colorectal cancer. World Journal of Gastrointestinal Surgery. 13(2). 210–221. 2 indexed citations
12.
Hu, Cegui, et al.. (2021). Molecular Subtypes and CD4+ Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer. Frontiers in Oncology. 10. 626912–626912. 18 indexed citations
13.
Huang, Chao, et al.. (2020). Identification of key genes controlling cancer stem cell characteristics in gastric cancer. World Journal of Gastrointestinal Surgery. 12(11). 442–459. 16 indexed citations
14.
Bu, Fanqin, Xiaojian Zhu, Xuan Yi, et al.. (2020). <p>Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients</p>. OncoTargets and Therapy. Volume 13. 11433–11444. 22 indexed citations
15.
Huang, Chao, Cegui Hu, Jinfeng Zhu, et al.. (2020). Establishment of Decision Rules and Risk Assessment Model for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. Frontiers in Oncology. 10. 1638–1638. 13 indexed citations
16.
Zhang, Wenjun, Cegui Hu, Jinfeng Zhu, & Hongliang Luo. (2020). Effect of P2X7 receptor on tumorigenesis and its pharmacological properties. Biomedicine & Pharmacotherapy. 125. 109844–109844. 43 indexed citations
17.
Kang, Lin, Jinfeng Zhu, Cegui Hu, et al.. (2020). Comprehensive analysis of the prognosis for chromobox family in gastric cancer. Journal of Gastrointestinal Oncology. 11(5). 932–951. 14 indexed citations
18.
Zhang, Wenjun, Cegui Hu, Hongliang Luo, & Jinfeng Zhu. (2020). Activation of P2×7 Receptor Promotes the Invasion and Migration of Colon Cancer Cells via the STAT3 Signaling. Frontiers in Cell and Developmental Biology. 8. 586555–586555. 21 indexed citations
19.
Zong, Zhen, et al.. (2020). Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer. Journal of Gastrointestinal Oncology. 11(4). 685–694. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xingyun Liao Breakdown of academic impact, for papers by Lian Zuo Breakdown of academic impact, for papers by Junya Peng Breakdown of academic impact, for papers by Yong-Kil Hong Breakdown of academic impact, for papers by Jian Wen Breakdown of academic impact, for papers by Ariungerel Gerelchuluun Breakdown of academic impact, for papers by Linda Spiegelberg Breakdown of academic impact, for papers by Ning Mu Breakdown of academic impact, for papers by Yumiko Yamamura
Rankless by CCL
2026